Ibritumomab and neutrophil count abnormal Patient Reports February 10, 2012

Ibritumomab Side Effects Report #4621325-0
Ibritumomab side effect was reported by a Health Professional from on Mar 23, 2005. Male patient, weighting 206.8 lb, was diagnosed with b-cell lymphoma and was treated with Ibritumomab. After drug was administered, patient experienced the following side effects: laboratory test abnormal, neutrophil count abnormal. Ibritumomab dosage: unknown. Patient recovered.